comprehensive -WSS

comprehensive

author：knowledge 2025-09-01 15:20:06 - browse：2774

Blood samples — Marion Berard/AFP/GettyImages

With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush.

Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.

“There’s going to be capacity issues because there’s just not enough neurologists in the world to treat this pool of patients with Alzheimer’s disease at the moment,” said Mark Stearman, a senior international product manager at Roche focusing on Alzheimer’s diagnostics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Maui wildfire now ranks as the fifth

entertainment

WSS

Bird flu in dairy cattle: New measures to control spread to humans

Scientific mystery highlights the blind spots in genomics databases

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Novo Nordisk touts Wegovy study, but still struggling with supply

Trial using CRISPR to edit HIV out of cells disappoints

Mass General Brigham physicians react to latest merger step

Wikipedia

comprehensive

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Medical records are filled with copy

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Hollywood unions extend contract negotiations for actors

Dozens dead from Maui wildfires: What we know about the victims

Dobbs anniversary: the lost opportunity of abortion as health care

Study: Black kids more likely to die after surgery than white kids

Heart attack and stroke risk calculators need revising

BMS, looking to build heart drug business, turns to AI for diagnosis

focus

YouTube cracks down on misinformation on cancer treatment

Pancreatic cancer is often deadly, but new discoveries are raising hope

What to know about the judge who will handle the Trump case

Drug companies' payments and gifts affect physicians' prescribing

Pancreatic cancer is often deadly, but new discoveries are raising hope

Maui wildfire now ranks as the fifth

hotspot

focus

entertainment

knowledge